What is KNSA's P/E ratio?

KINIKSA PHARMACEUTICALS LTD (KNSA) currently trades at a P/E ratio of 54.32.

KINIKSA PHARMACEUTICALS LTD reports a Return on Equity (ROE) of 12.06%.

What is KNSA's dividend yield?

KINIKSA PHARMACEUTICALS LTD offers a dividend yield of 0.00%.

What is KNSA's Deepscope Quality Score?

Deepscope rates KNSA's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy KNSA?

Deepscope's AI Timing Score for KNSA is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does KNSA belong to?

KINIKSA PHARMACEUTICALS LTD is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

Cổ phiếu KNSA (NASDAQ) | KINIKSA PHARMACEUTICALS LTD

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-12 | FS: 2026-03-31)

KNSA

KINIKSA PHARMACEUTICALS LTD

USD 51.89

0.31 (0.60%) Day Change

Watchlist Portfolio Compare Chart

54.32

P/E

0.01

D/E

12.1%

ROE

8.9%

ROA

0.00%

Div Yield

-0.22

PEG

KINIKSA PHARMACEUTICALS LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 51.89 Price 0.31 (0.60%) Day Change	NEWS SCORE: 99

KNSA Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	2007
Magic Formula Rank by ROE	2007
Magic Formula Rank by ROIC	1560
Price	51.89
PBV / Sector	6.55 / 2.65
Earning Per Share	0.96

PE / Sector	54.32 / 24.99
PEG or PE/Growth / Sector	-0.22 / 0.14
Average 1M Daily Value	26.09 M GREAT
Average 1W Daily Value	23.74 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	9.69 / 15.98
NPM Average (%) / Sector	19.34 / -16.38 GREAT
NPM Change Average (%) / Sector	-140.91 / 113.39
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	8.85 / 8.16
ROA Average (%) / Sector	10.34 / 2.38
ROA Change Average (%) / Sector	-165.15 / 108.63
ROE (%) / Sector	12.06 / -0.19
ROE Average (%) / Sector	12.42 / 7.40
ROE Change Average (%) / Sector	-172.38 / 371.95
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.52
Dividend Average (%) / Sector	N/A / 3.07
Dividend Change Average (%) / Sector	N/A / 14.36

Chi tiết đăng ký

Analyze Date	2026-06-13 11:14:00
Symbol	KNSA
Name	KINIKSA PHARMACEUTICALS LTD
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	46.30 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	3,968.46 / 10,015.19

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 105 Piccadilly, London, United Kingdom, W1J 7NJ

Phone: 44 78 1431 9100

Website: https://www.kiniksa.com

Employees: 366

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.